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Abstract. For biological and medical application, a definable nanomaterial and knowledge on its 
fate after administration are highly recommended if not mandatory. Here, we synthesized a 
water-soluble gold nanocluster by sodium borohydride reduction of chloroauric acid in presence 
of 5,5’-dithio-bis(2-nitrobenzoic acid). The resulting gold nanocluster displayed the physical 
characteristics of a cluster containing an inner core of about 100 gold atoms that was surrounded 
by an organic monolayer made of about 30 thioaminobenzoic acids (TAB) and 14 anionic 
thionitrobenzoic acids (TNB). The mixed TAB-,TNB-protected gold nanocluster reacted well in 
water with thiolated peptides containing a Nuclear Localization Signal (NLS) or a Nuclear 
Export Signal (NES) mainly by exchange of the TNB, providing gold nanoclusters equipped 
with 8-9 intracellular active peptides and a remaining ligand coverage consisting mostly of the 
zwitterion TAB. The behavior of these peptide-gold nanoclusters inside the cytosol and nucleus 
of cells was then assayed using an electroporation procedure allowing transient plasma 
membrane permeability. Light and electron microscopy observations demonstrated a consistent 
inflow and diffusion of the gold nanoclusters into the cytosol. Inside the living cells, the 
distribution of the gold nanoparticles was specifically driven by the appended signal peptides in a 
manner similar to the distribution of NLS and NES-bearing proteins, demonstrating diffusion 









Gold nanoclusters are attracting materials for biological applications because they can be 
tailored for photoluminescence,1 for protein inhibition2 glutathione detection3 or even sensitizing 
cancer cells to external radiation sources.4-6 The anionic mercaptobenzoic acid (MBA) has been 
used for producing water-soluble thiolate monolayer protected nanoclusters (AuNCs) of small 
sizes and even “magic” clusters with precise formula and structures.7-9 The gold cluster stabilized 
by an MBA-monolayer (AuMBA) could furthermore be conjugated to biological molecules, 
either by modifying the organic shell10-12 or by exchange/substitution of the gold-conjugated 
mercaptobenzoate with an incoming thiolated macromolecule.13 Bioconjugates derived from 
AuMBA have already proven useful for structural analysis of supramolecular assemblies in 
aqueous solution using cryo-Electron Microscopy (EM) techniques.10-12 They hold promise as a 
biomolecule-anchoring platform or as an imaging probe within living cells14 because the small 
and defined size of AuMBA should facilitate material characterization and diffusion in dense 
tissues15 and inside cells.16 To fulfill these intracellular application promises, passage across the 
plasma membrane and knowledge on the chemical and physical behavior of any nanomaterial 
inside the cytosol or nucleus are major challenging issues that still need to be resolved. First, the 
nanomaterial needs to be delivered into the cytosol, across the cell plasma membrane without 
impacting cell viability.17,18 In the majority of cases, the exogenous nanomaterial is tailored to bind 
to the cell surface for entrapment inside intracellular vesicles. When it contains as well elements 
able to lyse membranes, some leakage into the cytosol may occur but at an extremely poor 
efficiency. 19-22 Second, the chemical and physical behavior of the nanomaterial inside the cell 
should be compatible with the desired objectives. For performing these investigations, large 
entrapment of materials within intracellular vesicles severely hampers interpretation and data 
analysis. Use of an effective delivery method, which bypasses vesicular entrapment for action, 






Regarding the thiolate monolayer protected AuNCs, the intra-cytosol and intra-nucleus 
stability of the Au-S bond remains to be clarified. The Au-S bond has not been reported to be 
enzymatically cleaved but the cytosol contains thiols and particularly reduced glutathione (GSH) 
in a mM concentration range.23 Since AuNCs can easily exchange thiolate ligands in solution, 8,24 it 
is hence conceivable that the AuNC coupled thiolated ligand (i.e. the attached functional 
molecule) can suffer exchange with GSH inside living cells. Unstable Au-S bonds were observed 
for particles that were tailored to get majorly trapped in the intracellular lysosomal vesicles.3,6,24,25 
However, to our knowledge, no data were reported to clearly demonstrate whether the Au-S 
bond of thiolate-protected AuNCs inside the cytosol or inside the cell nucleus breaks up or 
remains steady.  
In this report, we develop a novel gold nanocluster allowing synthesis of definable peptide 
AuNC conjugates and then use an electroporation procedure to investigate the fate and behavior 
of bioactive peptide-AuNC conjugates inside living cells. First, we synthesized and characterized 
a new gold nanocluster (AuZ) in which the shell was mostly made of a zwitterionic 
thioaminobenzoic acid (TAB) because this ligand could stabilize the Au-S bond via a electron-
donating substitution,26 and because neutrally charged molecules can shield against unspecific 
interactions.27,28 Second, to probe the ability of peptide-grafted AuNCs to diffuse within the cell 
and the stability of the Au-S bond inside the cell, we selected peptide domains that selectively 
assist nuclear import or export of macromolecules through the nuclear pores. The AuZ was 
reacted with thiolated peptides containing the SV40 Nuclear Localization Signal (NLS), a 
mutated NLS defective for nuclear shuttling, or the Nuclear Export Signal (NES) of the protein 
kinase A inhibitor. The intracellular distribution of these peptide-grafted AuNCs was 
investigated after electroporation-mediated delivery. Light Microscopy and Transmission 
Electron Microscopy (TEM) imaging showed that the subcellular localization of the gold 
particles was specifically driven by the bioactive peptide’s coverage, demonstrating that these 






more than 4,000 molecules/cell and that the thiolated peptides remain stably coordinated to 
AuNCs for at least 24h in living HeLa cells. 
 
Results 
To obtain gold nanoclusters with zwitterionic ligands at a pH found inside cells, we tried a 
direct NaBH4 reduction of HAuCl4 in presence of 2,2’-dinitro-5,5’-dithiobenzoic acid (the 
Ellman’s reagent DTNB29) (Figure 1A), hoping that the anionic thionitrobenzoic acid (TNB) 
would be reduced to the zwitterionic TAB during the synthesis.30 The protocol described by Levi-
Kalisman and colleagues31 was slightly modified and cleanly led to a gold nanocluster (named 
AuZ) with a narrow mobility when analyzed by polyacrylamide gel electrophoresis (Figure 1B, 
inset image). The UV/visible absorbance of a 2.6 µM AuZ solution in 0.1 M HEPES, pH 7.4 
gradually decreased with an increase in wavelength (Figure 1B). The spectrum did not contain 
any absorption band at 409 nm characteristic of TNB and did not contain a surface plasmon 
resonance band at wavelengths above 520 nm. This UV/vis spectrum indicated formation of gold 
nanoclusters containing less than 140 gold atoms because Au144MBA60 and AuNCs of higher 
molecular masses possess a surface plasmon resonance band at 510-530 nm.21,32 A routine 1H 
Nuclear Magnetic Resonance (NMR) spectrum of the AuZ in D2O was apparently featureless 
(Figure 1C). The aromatic peaks of the thiobenzoic acids, normally between 6-8 ppm, were too 
broad to be visible. The broadening of the signal was attributed to intimate ligand immobilization 
on the gold particle’s surface that decreases the motion and the spin relaxation time of the 
analyzed atoms. It might also arise from the fact that Au-coordinated ligands have different 







Figure 1. Synthesis and analysis of the AuZ nanoclusters. A. Synthesis protocol. B. UV-vis spectrum of 
the gold nanocluster AuZ (2.6 µM, black line) or thionitrobenzoic acid (18 µM, blue line) in 0.1 M 
HEPES-Na, pH 7.4. The inset image is a polyacrylamide gel electrophoresis analysis of the AuZ. C. 1H 
NMR spectrum of 55 µM AuZ in D2O. The large peak at 4.7 is the signal of the D2O and was trimmed. 
Tertio-butanol (100 µM final concentration) was used as an internal standard. D. Cryo-electron 
microscopy images of AuNCs in a frozen non-crystalline aqueous solution (96 000 x). The right panel 
shows a gallery of 99 particles that were cropped from the left image. Statistical analysis on 95 particles 
gave a mean diameter of 1.42 nm and a standard deviation of 0.16 nm. E. MALDI-TOF mass spectrum of 






To analyze if the AuZ was fully dispersed in water, an AuZ solution was frozen for cryo-EM 
observation. Images showed mostly a population of individual particles of uniform spherical 
shape and size (Figure 1D).35 Assuming a spherical morphology for all particles, statistical 
analysis on 95 particles gave a mean diameter of 1.42 nm with a standard deviation (S.D.) of 
0.16 nm. This diameter corresponds to a metallic cluster of 88 gold atoms using the volumetric 
mass density of Au (19.3 g.cm-3). The real diameter of the particle is likely slightly above this 
mean value because of the applied defocus and delocalized scattering electrons. The MALDI-
TOF mass spectrum (MS) of AuZ displayed a population of molecular masses centered at 21,240 
Da (Figure 1E). This pattern was strikingly similar to the one published for Au102MBA44 
(calculated molecular mass of 26.83 kDa) where a broad distribution of masses centered at 21 
kDa was obtained, suggesting that the laser-induced desorption and ionization condition 
promoted in both cases similar sample degradation.31  
The AuZ was next analyzed by X-ray Photoelectron Spectroscopy (XPS) (Figure 2A). The 
XPS survey spectrum showed the characteristic peaks of Au 4f, Si 2s, S 2p, C 1s, N 1s and O 1s. 
The Si 2s peak (around 150 eV) originates from the Si wafer substrate and no other elements are 
detected. High-resolution analysis of S 2p, and C 1s peaks confirmed that all the aromatic 
thiolates were fully coordinated to the gold surface (Supporting Information, Figure S1). The N 
1s region (inset of Figure 2A) reveals three distinct nitrogen species with peaks at 399.1 eV, 401 
eV and 405.9 eV. The peaks at 399.1 and 401 eV can be assigned to an aromatic amine (the 
TAB) and an ammonium (likely residual ammonium counterions), respectively.36 The N 1s peak 
at 405.8 eV was ascribed to NO2-groups37 and originated from the TNB. Integration of the N 1s 
peaks led to a TAB/TNB ratio of 2.12, suggesting that 68% of the nitro groups were reduced to 
amines during the nanocluster synthesis. The Au 4f7/2 photoelectron peak of the AuZ was shifted 







Figure 2. XPS spectra of AuZ particles A. survey spectrum with high resolution N 1s core level spectrum 
included in the inset. B. Au 4f core level peak and C. valence band. The Au 4f and valence band spectra 
of metallic Au(0) sample are shown for comparison.  
 
In the same time, the spin-orbit splitting ESO of AuZ (2.32 eV) was reduced relative to the ESO of 
polycrystalline Au(0) (2.74 eV) (Figure 2C). Using the published relationship between the gold 
particle size and these values, the AuZ cluster contains on average 103±32 Au atoms.38 The XPS 
analysis suggested that AuZ is reminiscent of a 102 gold atom cluster, which corresponds to a 






“magic” cluster, it is surrounded by 44 ligands, here 30 TAB and 14 TNB using the XPS 
integration ratio, leading to a hypothetical formula of Au102TAB30TNB14.  
 
 
Figure 3. Survey on the ligand exchange ability of the AuZ gold nanocluster using reduced glutathione 
(GSH). A. Schematic view of the reaction. The inset image is a PAGE analysis of the AuZ and GS-
grafted AuZ (AuGS). B. 1H NMR spectra of the crude reaction mixture, purified solution containing <10 
kDa components and purified resulting gold nanocluster (AuGS). The large peak at 4.7 ppm is D2O and 
was trimmed. The peaks between 2-4.7 ppm are assigned to GSH and the ones between 6.5-8.0 ppm 
correspond to released thionitrobenzoic acid (TNB), thioaminobenzoic acid (TAB) or mixed TNB-, TAB- 
disulfides. The AuZ (150 µM) and GSH (6000 µM) in D2O containing tert-butanol (100 µM) as an 
internal standard were incubated for 20h at 20°C. The crude reaction was purified using a dialysis 






A thermogravimetric analysis (TGA) was also performed to determine the percentage of 
organic materials covering gold clusters since this organic layer decomposes and becomes 
volatile upon heating at a temperature below the metallic gold (Supporting Information, Figure 
S2).9,31 A total weight loss of 25.5% was obtained and the TGA showed a biphasic profile with a 
first 6.8% weight loss occurring at 212°C and a second 14.8% weight loss occurring at 420°C. A 
small discrepancy is observed between the observed 25.5% total weight loss and the calculated 
29.2% one for Au102TAB30TNB14 but appears within the accuracy range of this method.9,31 We 
suggest that the minor 6.8% weight lost originates from thermal decarboxylation of the 44 
ligands (calculated value of 6.9%).39 The ability of the ligands covering the AuZ to be exchanged 
with incoming water-soluble thiols in aqueous solution was then assayed using reduced 
glutathione (GSH) (Figure 3A). When the AuZ (150 µM) was reacted with 40 molar equivalents 
of GSH, a Glutathione-modified AuZ (AuGS) with an increased electrophoretic mobility in 
comparison to AuZ was obtained (Figure 3A, Inset image). To further analyze the thiolate 
ligand-exchange reaction, we performed an experiment using NMR spectrometry because the 
signal of the Au-bound ligands of the AuZ were hardly detectable using routine NMR settings 
that are used to analyze small organic molecules (see Figure 1B). If exchange occurs, the 
aromatic ligands should be released in solution and their NMR signals be hence detected. The 
AuZ (150 µM) was reacted with 40 molar equivalents of GSH in D2O and a NMR spectrum of 
the crude mixture was taken after 20h incubation at 20°C (Figure 3B). The spectrum exhibited 
peaks between 6.5-8.0 ppm, which were unseen in the AuZ spectrum. The aromatic NMR signals 
are attributed to hydrogens of TNB, TAB and mixed disulfides with GSH, suggesting indeed 
ligand release from the AuZ surface. Integration of the NMR signals indicated that TNB and 
TAB were released in equal amounts. Using tertio-butanol as an internal standard, the 
concentration of released ligands was estimated at roughly 1700 µM or 11.3 ligands/particle with 
a TNB/TAB ratio of 1. This ratio is higher than the initial TNB/TAB ratio of 0.46 present at the 






the ligand aromatic ring.8,26 A dialysis fractionation device with a 10 kDa cut-off was then used to 
afford solutions containing either the high molecular mass AuGS or <10 kDa species. Both 
solutions were lyophilized and the residues were analyzed again. The solution containing <10 
kDa species presented a slightly different NMR profile in the 6.5-8 ppm range in comparison to 
the crude solution. This is likely due to slight acidity variation and to complete air-mediated 
oxidation of thiols to disulfides. The narrow signals (1.8, 2.7, 2.8 and 2.9 ppm) could not be 
attributed. They likely came from soluble stabilizers present in the dialysis fractionation device. 
An MS analysis of this solution confirmed disulfide formation and TAB release because an MH+ 
of 475.06 corresponding to the MH+ of GSH-TAB disulfide was detected (Supporting 
Information, Figure S3). The NMR spectrum of purified AuGS was featureless above 4.7 ppm 
but displayed broad peaks at 2.2 and 3.7 ppm, attributable to Au-bound glutathiones that have 
different local chemical environment and restricted mobility in a similar manner than aromatic 
ligands behaved when they are bound to the AuZ’s surface (Figure 1C).40 
 
Synthesis of peptide-substituted gold nanoclusters 
The AuZ was reacted in HEPES buffer pH 7.4 with increasing amounts of the thiolated peptide 
HS-NLS which contains an N-terminal Cysteine, followed by the ALNNG sequence that was 
shown to prevent the metallic gold core from aggregation41 and then the SV40 NLS sequence 
(Figure 4).42 The reaction products were analyzed by polyacrylamide gel electrophoresis (SDS-
PAGE) and Coomassie blue staining to reveal as well the peptide (Figure 4B). In the reaction 
mixture at HS-NLS/AuZ ratio of 24, excess peptide (fast moving blue band) was observed, 
indicating saturation of the substitution sites on the AuZ surface. When the HS-NLS/AuZ ratio 
was gradually increased from 1 to 24, 8 different bands with gradual retardation were observed. 
By correlating the HS-NLS/AuZ ratios and the bands, we presumed that NLS peptide-AuNC 







Figure 4. Reactivity of the AuZ with thiolated peptides. A. Schematic view. B. PAGE analysis of the 
reaction between AuZ and thiolated Nuclear Localization Signal Peptide (HS-NLS) at increasing molar 
ratios. *: HS-NLS alone. Last right lane: protein standards. Left numbers point to new gold clusters with 
different electrophoretic mobilities. C. PAGE analysis of AuZ and purified peptide-substituted gold 
nanoclusters made at a peptide/AuZ input molar ratio of 32. Cap: CALLNG, NES (Nuclear Export Signal 
peptide): CALNNGLALKLAGLDINKTamide, NLS (Nuclear Localization Signal): 
CALNNGAGPKKKRKVED, dNLS (defective NLS): CALNNGAGPKTKRKVED. Gels were stained 







Several peptide-gold nanocluster conjugates were similarly prepared by incubating AuZ with 
respectively the CALLNG peptide alone (Cap), the Cap linked to the protein kinase A inhibitor 
Nuclear Export Signal peptide (NES),43 the HS-NLS and a defective NLS peptide (dNLS) in 
which one lysine was replaced by a threonine.42 To ensure full substitution, the peptide/AuZ feed 
ratio was set at 32. The peptide-substituted AuNCs were then purified from the excess of free 
peptides and released ligands by dialysis. PAGE analysis showed that the Cap-substituted AuNC 
(AuCap) migrated as a single band with electrophoretic mobility similar to the starting AuZ as 
expected by the size and net charge of the Cap peptide that matches that of TNB (Figure 4C). 
The NES- and dNLS-substituted AuNCs (respectively AuNES and AudNLS) were significantly 
retarded and had an electrophoretic mobility close to NLS-substituted AuNC (AuNLS), 
suggesting that each gold nanocluster was also covered with 8-9 peptides. The AuNLS displayed 
a MALDI-TOF mass spectrum containing one major population (maximum at 20.6 kDa) and 
minor humps at higher molecular weights (Figure 4D). As previously found for AuZ (Figure 1E), 
the major population can be assigned to an AuNC species devoid of the organic coverage which 
was presumably fragmented by the laser-induced desorption and ionization.31 The novel humps 
were remarkably equidistant by a value (1.8 kDa) corresponding to the molecular mass of the 
HS-NLS peptide, suggesting that AuNCs equipped with 1 to 5 NLS peptides partially sustained 
degradation imposed by the analytical process. The MS of AuCap, AudNLS and AuNES 
(Supporting Information, Figure S4) exhibited similar molecular weight patterns. The peptide-
substituted AuNCs were finally analyzed by electron microscopy (Figure 5).  The AuNCs 
differently stuck to the Carbon film but were homogenous in diameter (average apparent 
diameters of 1.4 nm) suggesting that these ligand exchange conditions were producing little 







Figure 5. Transmission Electron Microscopy images of the peptide-modified gold nanoclusters. A. 
AuNLS. B. AudNLS. C. AudNLS. D. AuNES. 
 
Fate of AuNCs following cytosolic delivery inside living HeLa cells  
An electroporation protocol creating transient holes in the plasma membrane to direct influx of 
proteins inside the cytosol without inducing cellular lethality was described.44 The similarity in 
terms of size between AuNCs and proteins suggests that this electroporation procedure might 
also promote a direct influx of gold nanoparticles into the cytosol of living cells. This delivery 
method, which does not rely on any particular design of the particles or passage through 
vesicular compartments, creates an opportunity to precisely analyze the intracellular behavior of 
peptide-modified gold nanoclusters and whether they can diffuse and remain stable within the 






The effect of the peptide-substituted AuNCs on the viability of native HeLa cells and 
transiently permeabilized HeLa cells (done using an electroporation device) was explored using a 
MTT assay (Figure 6).45 The experimental conditions were the ones that were optimized for the 
effective antibody transduction with minimal cell toxicity.44 The cell viability was measured 24h 
after addition of the AuNCs and application of the electric pulses. Addition of AuNCs to HeLa 
cells with unimpaired cell plasma membrane (no electric pulses; blue bars) did not promote acute 
cytotoxicity (viability measured at above 75% for all AuNCs). Apparent cytotoxicity was also 
not observed when the plasma membrane was transiently permeabilized using electric pulses, 
regardless of the peptide-substituted AuNCs (yellow bars). A similar low cytotoxicity profile 
was also observed using the non-cancerous human fibroblast HFF-1 cell line (Supporting 
Information, Figure S5). 
 
 
Figure 6. Evaluation of the HeLa cell line viability in presence of the peptide-substituted AuNCs (blue 
bars) and with electric pulses allowing transient permeabilization of the plasma membrane (yellow bars). 
Viability was measured 24h after addition of the AuNCs. Values are averages and standard deviation of 







Next, the AuCap, AuNLS and AudNLS were incubated with freshly trypsinized HeLa cells for 
30 min without or with an electroporation treatment and the cells were left to adhere and grow 
for 24 h onto glass lamella. After cell-fixation, the gold particles were revealed using a silver 
staining procedure (Figure 7). For AuNCs that were incubated with the cells in the absence of the 
electric-induced membrane-permeability (Figure 7A), gold nanoclusters were mostly observed at 
distinguishable perinuclear compartments resembling lysosomes. This perinuclear accumulation 
was not unexpected since any binding to the cell outer-membrane surface can trigger a dynamic 
entry into intracellular vesicles and sequestration into lysosomes.46,47 When the same AuCap, 
AuNLS, AudNLS nanoclusters were mixed with HeLa cells and then subjected to electric pulses 
for transient plasma membrane permeabilization(Figures 7B),44 the intracellular silver staining 
was greatly enhanced as compared to non-electric pulsed-cells, indicating that the gold 
nanoclusters penetrated into cells through the plasma membranes upon the transient electric 
pulse-induced pores. The AuCaps were dispersed throughout the cytoplasm and the nucleus 
indicating that they can freely diffuse throughout the cell. The AuNLS strongly accumulated in 
the cell nuclei. In contrast, the mutated AudNLS carrying a defective NLS was spread 
throughout the entire cell. Important to mention, most adherent cells containing the different 
AuNCs had an adherent morphology similar to untreated cells, confirming the MTT assay ant 
that electroporation and cytosolic-delivered nanoclusters do not dramatically interfere with the 
cellular physiology of this cancer cell line. Observation of a sequence-specific nuclear import of 
the gold nanocluster clearly demonstrated that the gold-coupled NLS peptides remain 







Figure 7. Illustration of each experimental procedure and optical micrographs of Hela cells incubated for 
24h with the indicated peptide-substituted gold nanoclusters (AuNCs). A. The various peptide-AuNCs 
were added to HeLa cells in suspension. The cells were then added into wells for cell adhesion and 
monolayer formation. B. The various peptide-AuNCs were added to HeLa cells in suspension and the 
mixture treated with electric pulses for transient membrane permeabilization. The cells were then added 
into wells for cell adhesion and monolayer formation. Following the 24h incubation period at 37°C, the 
cells were fixed with glutaraldehyde (2.5% w/v) and subjected to silver staining for AuNC detection. 
 
To further evaluate the diffusion ability of the AuNC and the stability of the Au-S bond in the 
nucleus, we evaluated as well a peptide signal-assisted nuclear export using the nuclear export 







Figure 8. Optical micrographs of Hela cells incubated for 24h with the AuNES.  A. Addition of 
AuNES to non-permeabilized HeLa cells. B. AuNES and HeLa cells were subjected to electroporation 
with or without leptomycin, an inhibitor of the NES-dependent nuclear export machinery. Following the 
24h incubation period at 37°C, the cells were fixed with glutaraldehyde (2.5% w/v) and subjected to 








Addition of the AuNES to native non-permeabilized HeLa cells led to nanocluster accumulation 
in perinuclear compartments (Figure 8A) in an analogous manner than AuCap, AuNLS and 
AudNLS did. When the AuNES and the HeLa cells were subjected to electroporation and when 
the NES-dependent nuclear export was inhibited by leptomycin,48 the intracellular AuNES was 
homogeneously dispersed inside the entire cell, including the nucleus (Figure 8B, left image). In 
the absence of leptomycin, the nuclear export machinery was fully functional. In this condition, 
hardly any AuNES was detected in the nuclei (Figure 8B, right image) but rather appeared to 
localize and aggregate in subcellular organelles. Such redistribution is analogous of that 
observed with NES-grafted fluorescent proteins.43 Similar specific peptide-mediated nuclear 
in/out shuttling of AuNCs were obtained using the U2OS cell line and the non-cancerous human 
fibroblast HFF-1 cell line (Supporting Information, Figures S6 and S7), indicating that the 
observation was not HeLa-specific and can be extended to another cell lines. 
 The intracellular distribution of AuCap, AuNLS and AuNES within HeLa cells was further 
investigated by Transmission Electron Microscopy (TEM) 24h after the electroporation 
treatment (Figure 9). The gold nanoclusters were grown to 8-13 nm diameter particles by silver-
enhancement of specimens before resin-embedding in conditions that do not produce auto-
nucleated silver particles (Supporting Information, Figure S8).14 The electroporation treatment 
and the presence of gold particles did not lead to any visible histological modification of the 
HeLa cells and the images showed similar gold nanocluster distribution patterns to those 
observed in light microcopy. The AuCaps were detected as single particles or in groups, both in 
the cytoplasm and in the nucleus in a roughly equivalent proportion (Figure 9, left image). The 
AuNLS were mostly detected as individual dots in the nucleus at areas with low heavy-metal 
contrast, corresponding probably to areas of the nuclei devoid of condensed chromatin (Figure 9, 
middle image). In a representative cell section 100 silver-amplified particles were counted in the 






cytoplasm, including 3 particles that were clearly entrapped inside vesicular bodies. Knowing the 
volume of the HeLa cell nucleus (374 µm3),49 we calculated that the entire nucleus contains about 
4,860 AuNLS. The AuNES were barely detected inside the nucleus and were seen to congregate 
in cytosolic areas (Figure 9, right image).  
 
 
Figure 9. Transmission electron microscopy images of Hela cells after cytosolic delivery of peptide-
substituted gold nanoclusters as indicated. A. TEM images. Individual 8-13 nm diameter dark dots, 
corresponding to amplified AuNCs, were visualized on the micrographs at high magnification then 
highlighted in circles; aggregates of AuNCs were featured as columns; cytoplasmic and nuclear 
localizations were colored in black and red, respectively. B. Illustration of the imaged cells along with the 
position of AuNCs. The different peptide-AuNCs were delivered by electroporation into the cytosol of 
HeLa cells. The living cells were incubated for 24h at 37°C and then processed for electron microscopy 
observation. The AuNCs were mildly silver-enhanced to ensure AuNC detection and ultrastructure 









Availability of definable nanomaterials for any applications is really helpful and promises 
reliability. First we demonstrated the feasibility of preparing highly homogeneous gold 
nanoclusters, which can be further grafted with several thiolate-containing active peptides. A 
new type of gold nanoclusters of uniform size was synthesized from chloroauric acid and the 
Ellman’s reagent upon reduction with sodium borohydride. Seventy percent of the TNB was 
reduced to the zwitterionic TAB during the nanocluster formation and was likely assisted by the 
presence of gold atoms.30 The UV/vis spectrum, cryo-EM image of AuZ in a vitrified aqueous 
solution, MALDI-TOF MS, XPS, TGA and theoretical calculation on cluster stability50 support 
the formation of gold clusters nearing the Au102(TAB)30(TNB)14 formula. Although not exclusive, 
the TNB ligand exchanged more readily than the TAB when reacted with external thiolated 
molecules, leaving a surrounding shell consisting of grafted peptides and mainly of the 
zwitterionic TAB ligand. The properties of AuZ and peptide-substituted AuZs to migrate as 
discrete bands in polyacrylamide gels are highly valuable for materials characterization. PAGE 
analysis is for instance not suited for characterization of less definable citrate-stabilized 4.5 nm 
gold nanoparticles (Figure S9). In our hands, AuZ was also substantially easier to produce as a 
single particle population than the AuMBA as judged by PAGE analysis (Figure S10). 
Second, we evaluated the diffusion abilities and the fate of bioactive peptides-substituted AuZs 
when added to living cells for which the plasma membrane was transiently impaired by electric 
pulses. The remaining live cells adhering to lamella were seen to contain diffusible AuNCs and 
peptide-AuNC conjugates that shuttle across the nuclear envelop in a peptide-dependent manner. 
Altogether, our aggregated data clearly demonstrated that peptides remained grafted onto the 
gold nanoclusters (i.e.: the Au-S is stable) for at least 24h inside the cytosol and nucleus of cells. 
These AuNCs were also small enough to pass through electric pulses-mediated holes in the 
plasma membrane and mobile inside the cytosol and in the nucleus. This observation was in 
sharp contrast to a similar experiment in where 4.5 nm diameter gold nanoparticles did not 






of other types of gold particles and cytosolic/nuclear localization can be found in the literature. 
For example, PEGylated 2.4 nm gold particles16 or tiopronin-protected ca. 3 nm particles,51 when 
equipped with Cell Penetrating Peptides (CPP) having an adventitious NLS, were detected in the 
nucleus 1 to 3 h after addition to living cells but the efficiency of the process was unfortunately 
not quantified. Gold particles larger than 5.5 nm in diameter were also similarly equipped with 
CPP but their intracellular distribution appeared heterogeneous and experiment-dependent, 
ranging from exclusive entrapping onto the cell surface and in cellular vesicles16,52 or alternatively 
penetration into the nucleus.19,52-54 Gold particles in the nucleus were in some cases accompanied by 
a dramatic modification of cell morphology,52 indicating that these materials interfered with an 
important cellular mechanism, leading to cell death. In other cases, the nuclear distribution of 
gold particles53 and of photoluminescent 2 nm gold nanoclusters4,5 was heterogeneous, suggesting 
strong non-specific interactions with nuclear components and/or impaired diffusion. Additional 
insight into the ability of gold nanoparticles to traffic to the cell nuclei were obtained by grafting 
different and independent bioactive organic species to gold particles of about 15 nm in 
diameter.19,54 However,  when quantitative analysis was done, only a small portion and number 
(<10) of the multifunctionalized particles were detected in the cell nuclei, questioning their 
nuclear targeting abilities in regard to statistical significance. 
In here, the electroporation protocol provided a significant improvement in cytosolic delivery 
of small and diffusible gold nanoclusters over previously reported methods undergoing a passage 
into intracellular vesicles. Almost 100% cells contained AuNCs inside the cytosol or into the 
nucleus and the materials within intracellular vesicles did not overwhelm the ones inside the 
cytosol (Figures 7 and 8; Supporting Information, Figures S6-7). The delivery efficiency in term 
of quantity (for instance, >4,000 nuclear particles per cell using the AuNLS) was also 
appreciated and considerably facilitated data analysis. In our investigation, the electroporation 
protocol helped demonstrating that peptide-conjugated AnNCs (either the AuNLS or the 






in a protein-like manner. This finding clearly implies a stable Au-S bond between the AuZ and 
the thiolated active peptide for at least 24h. It opens some intracellular usages of the definable 
AuZ gold nanoclusters which are amenable to facile derivatization with bioactive peptides or 
organic ligands and have mobility into the densely packed intracellular environment. The 
AuMBA has similar properties than the AuZ (Supporting Information, Figure S10). An NLS-
grafted AuMBA also accumulated in the cell nuclei using the electroporation treatment 
suggesting that the intracellular stability of Au-S coordination bond is insensitive to neighboring 
ligands. Nuclear accumulation of the NLS-grafted AuMBA in the non-cancerous HFF-1 cells 
appeared nonetheless less intense than that of the NLS-grafted AuZ (Figure S10D), suggesting in 
fine that the nanocluster-bound zwitterionic TABs might diminish undesired association to the 
HFF-1 cytoskeleton and represent an improved coverage in comparison to the anionic MBAs.  
 
Conclusion 
We have synthesized a novel monolayer organothiolate-protected gold nanoparticle by NaBH4 
reduction of a mixture containing chloroauric acid and the Ellman’s reagent. The procedure 
essentially yielded a uniform gold nanocluster, which is easily isolated by precipitation with 
excess methanol. Analytical data of this gold nanocluster characterized it as close to a superatom 
cluster containing 102 gold atoms, which are surrounded by an organic monolayer made of about 
30 thioaminobenzoic acids and 14 thionitrobenzoic acids. These ligands, preferentially the 
thionitrobenzoic acids, are readily exchanged with thiolated peptides in aqueous solutions, 
providing gold nanoclusters that are grafted with ca. 8-9 peptides and mainly coated with 
remaining zwitterionic TAB ligands. The peptide-gold nanocluster conjugates can furthermore 
be delivered via an electroporation treatment into the cytosol of living cells wherein the Au-S 
coordination bond between thiolated peptide an≈d Au(I) at the surface of the Au102 nanocluster 
was stable for at least 24h. Altogether, we have synthesized new definable gold nanoclusters and 
peptide-AuNC conjugates. We have also demonstrated the usefulness of electroporation for 






surface-modified gold AuNCs inside the cytosol and cell nucleus in where they can diffuse and 
specifically associate to molecular transport machineries. These data opened the usage of precise 
peptide-functionalized gold nanoclusters for intracellular investigation and application. These 
AuNCs might be particularly useful for building novel EM probes for high-resolution 
immunolabeling inside living cells. 
 
Experimental section 
General. Materials and additional protocols are described in the supporting information. 
Gold nanocluster synthesis. The synthesis was done following a described procedure.31 
Hydrogen tetrachloroaurate(III) trihydrate (14.2 mg, 36 µmol), DTNB (24.4 mg, 54 µmol), 
NaOH (13 mg, 324 µmol) and NaBH4 (4mg, 108 µmol) were mixed in a methanol/water solution 
and the mixture was shaken overnight. The gold clusters were then precipitated by addition of a 
2 M AcONH4 solution (2 mL) and methanol (34 mL). The black pellet (gold nanoparticle) was 
resuspended in water and desalted by a size exclusion chromatography (Sephadex G50). The 
black fraction was lyophilized resulting in AuZ (4.2 mg, 152 nmol) as a black powder. 
Ligand exchange reaction with an increasing ratio of thiolated peptide to gold nanocluster. The 
thiolated NLS peptide was freshly diluted in water to 1 and 4 mM concentrations. Aliquots (0.8 
and 1.6 µL of the 1 mM NLS peptide solution and 0.8, 1.6, 2.4, 3.2 and 4.8 of the 4 mM NLS 
peptide solution) were carefully dispensed at the bottom of different 0.5 mL tubes. The AuZ (10 
µL of an 80 µM solution in 100 mM HEPES pH 7.4, 0.8 nmol) was then rapidly added to each 
tube containing the peptide (0.8, 1.6, 3.2, 6.4, 9.6, 12.8 and 19.2 nmol). The mixtures were then 
incubated for 18h and reaction products were analyzed by electrophoresis on a 10% 
polyacrylamide gel. 
Peptide-coated gold nanoclusters. A solution of 80 µM AuZ (80 µL in 100 mM HEPES pH 
7.4, 6.4 nmol) was rapidly added to a solution containing 10 mM thiolated peptide (20.5 µL, 205 
nmol) and 50 mM TCEP, pH 7.4 (4.3 µL, 215 nmol) which was previously dispensed into a 0.5 






mixture was then diluted with water to 0.5 mL and the gold nanoparticles were purified from low 
molecular weight components using 0.5 mL Microcon® 30 kDa centrifugal filter device (Merck, 
Molsheim) and 7 centrifugation cycles (2 x water, 2 x 0.4 M NH4HCO3 and 3 x water). The 
concentration of the nanocluster was determined by measuring absorbance at 520 nm and a e520 of 
2.7 x 105 mol-1 x L x cm-1. Final concentrations were adjusted to 80 µM in AuNC with water. 
About 70 to 80% of the gold nanoparticles were recovered. The gold nanoparticles were 
analyzed using PAGE. 
Ligand exchange measured by NMR spectroscopy. The gold nanocluster (3.2 mg, 120 nmol) 
was dissolved in D2O (0.5 mL). The concentration was determined by measuring absorbance at 
520 nm. The cluster was then diluted in D2O to a final concentration of 150 µM. A 0.6 mL 
volume was withdrawn and taken for 1H NMR analysis at 293 °K. Tertio-butanol (final 
concentration of 0.1 mM) was used as an internal standard. A 0.3 M glutathione, pD 7.4 was 
freshly prepared in D2O. An aliquot (12µL, 3600 nmol) was added to the 150 µM AuNCs (600 
µL, 90 nmol). The 1H NMR spectra were then collected 2 and 6h later. The crude solution was 
then purified using a 0.5 mL Microcon® 10 kDa centrifugal filter device (5 times water). The 
flow-through containing the species with molecular masses < 10 kDa and the AuNC solutions 
were lyophilized, dissolved in D2O (0.6 mL) and the 1H NMR spectrum was recorded again.  
XPS analyses. A 10 µM nanoparticle solution in water/methanol (9/1)(20 µL) was deposited 
onto a silicon wafer support. The water/methanol was left to evaporate in air under a fume hood 
and the sample was dried under high vacuum. The XPS measurements were performed in a UHV 
setup equipped with a monochromatic Al K𝛼 X-ray source and a VSW Class WA hemispherical 
electron analyzer.55 The binding energy scale of the spectrometer was calibrated prior to the 
measurements and since samples did not have electrostatic charging, the binding energies are 
presented without any correction. The Shirley method was employed for background subtraction, 
prior to the fitting procedure. The elemental atomic ratio was calculated by the integrated XPS 
peak areas of high resolution spectra normalized to the atomic sensitivity factors and by 






Electroporation Protocol. Transduction experiments were conducted as previously described 
using the NeonR transfection system and three 10 ms pulses at 1550 V.44 For light microscopy 
imaging, HeLa cells (105 cells in 12 µL of the Neon Buffer R) were mixed with each AuNC (80 
pmol, 1 µL of a 80 µM solution). For TEM imaging, the electroporation was scaled up 6 fold (6 
X 105 cells in 110 µL Neon Buffer R, 6 µL AuNCs). After the electric pulses, the cells were 
diluted into prewarmed cell culture medium without antibiotics (1 mL). The cells were recovered 
by gentle centrifugation, suspended into the warmed complete cell culture medium without 
antibiotics and added into wells of 24-wells plates for cell adherence and cell growth into a cell 
culture incubator. 
Cell viability assay. The assay was done according to a published procedure.57 The AuNCs and 
the cells mixtures were treated as described in the electroporation protocol and then diluted for 
culture in 96-wells plate. Assay was performed 24h after addition of the sample. 
   
Cellular Specimen preparation for Light Microscopy. 24h after the electroporation treatment, 
the cell monolayers were washed with warmed (37°C) Sorenson’s buffer (3 x 1 mL). The cells 
were then fixed with 2.5% glutaraldehyde diluted in 133 mM Sorenson’s buffer (1 mL) for 1h. 
Unreacted aldehydes were blocked by incubation with a 100 mM Sorenson’s buffer, pH 7.4 
containing 50 mM glycine (1 mL, 20 min). The plasma membrane was permeabilized using 
0.1M Sorenson’s buffer pH 7.4 containing 0.05% (w/v) saponin (1 mL, 15 min) before 
proceeding for silver-mediated amplification of the gold particles according to a modified 
Danscher protocol58 using silver acetate and propyl gallate.59 The glass plates were mounted on 
slides (StarFrost, Knittel Glass, Germany) and samples were observed using a Leica DM5500B 
microscope equipped with a Leica DFC350FX camera. Image acquisition was made with Leica 
LAS AF software. 
Cellular Specimen preparation for Electron Microscopy. 24h after the electroporation 
treatment, the adherent cells were washed with warmed (37°C) Sorenson’s buffer (3 times 2 






were then washed with TEM storage solution (5x, 1 mL). Enhancement of sizes of the gold 
particles with silver was performed using the SE-EM kit (Aurion, the Netherlands) and according 
to the manufacturer’s protocol. The cells were then contrasted with 0.5% osmium for 20 min 
followed by 2% uranyl acetate both diluted in water. The specimens were then dehydrated in a 
solution containing increasing concentrations of ethanol and flat embedded in epon (Ladd 
Research Industries, Williston, Vermont, USA). The resin-embedded specimens were sectioned 
into 100 nm thick slices that were deposited on a 200 mesh electron microscopy grid. 
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Complement to Materials and Methods  
 
Chemicals 
5,5’-dithio-bis(2-nitrobenzoic acid)(DTNB) (Sigma-Aldrich D8130) 
Hydrogen tetrachloroaurate(III) trihydrate (Sigma-Aldrich 520918-1G) 
Sodium borohydride (NaBH4) (Aldrich 45,288-2) 
Sodium hydroxide (Fluka 71691) 
4-(2-Hydroxyethyl)-piperazine-1-ethanesulfonic acid, N-(2-Hydroxyethyl)piperazine-N′-(2-
ethanesulfonic acid) (HEPES) (Euromedex 10-110)  
Trishydroxymethylaminomethane base (Tris) (Euromedex, 26-128-3094B) 
Glycine (Gly)(Euromedex 26-128-6405C) 
Peptides were purchased from GeneCust (Dudelange, Luxembourg)  
Glutathione reduced (GSH) (Sigma G6013-5g) 
Methanol (Sigma-Aldrich 179957-5L) 
Water Bi-distilled  
Tris(2-carboxyethyl)phosphine hydrochloride (Sigma-Aldrich BioUltra 75259) 
Ammonium hydroxide 28% (EMS cat#10600 EMS group, Hatfield, PA, USA) 
Glutaraldehyde 25% solution EM grade (EMS cat#16220, EMS group, Hatfield, PA, USA) 
HSPEG (Code PEG1169-0005, MW 2015Da, Iris Biotech, Germany) 
 
Materials. The pH-meter was a Hanna HI2210 instrument combined with a HI 1131B electrode. 
Centrifugation of 50 mL solutions was performed using an Eppendorf 5810R centrifuge and the 
rotor A-4-81. Centrifugation of small volumes (0.5 to 2 mL) was performed using a Sigma 1-
15K Eppendorf centrifuge with a 12132-H rotor. For gold particle formation, agitation was 
performed on a rocking platform (Heidolph Rotamax 120). The Nuclear Magnetic Resonance 
(NMR) data were taken with a Bruker DPX 400 MHz spectrometer. The UV-vis absorbance 
spectra were recorded using a Varian Cary 100Bio spectrometer. Nanoparticles were purified 
and concentrated using 0.5 mL Microcon® centrifugal filters (Merck, Molsheim) with cut-off of 
10 or 30 kDa according to the manufacturer’s specification. The spectrofluorometer was a 








Small volumes of aqueous solutions were dispensed using pipettes (Gilson Pipetman® classic 
P10, P100, P1000 models). Large volumes were dispensed using serological pipettes (Falcon® 5 
10 or 25 mL) and a single channel Omega Pipettor (Argos Technologies Inc, Elgin IL). 
Reactions were performed unless indicated in polypropylene tubes of different volumes (50 mL, 
15 mL, 2.0 mL, 1.5 mL or 0.5 mL).  
 
Preparation of aqueous stock solutions 
- Peptides were made at 10 mM concentration in water and stored in aliquots at -20°C. 
- Tris(2-carboxyethyl)phosphine (TCEP), 0.1 M solution, pH 7.4 was prepared by incremental 
addition of 2 M NaOH to a 0.2 M TCEP hydrochloride (286.65 mg in 5 mL H2O) solution under 
stirring and by monitoring pH increase with a pH-meter. When the pH reached 7.4, the TCEP 
solution was set at 0.1 M and stored in aliquots at -20°C.  
- 4-(2-Hydroxyethyl)-piperazine-1-ethanesulfonic acid, N-(2-Hydroxyethyl)piperazine-N′-(2-
ethanesulfonic acid) (HEPES) (23.83 g, 0.1 mol) was dissolved in water (50 mL). The pH was 
adjusted to pH 7.4 with incremental addition of 1M NaOH and using a pH-meter. The solution 
was then adjusted to 100 mL and was filtered for sterilization using a 33 mm syringe-driven filter 
unit (0.22 µm Millex-GP, Millipore, Molsheim France). The 1M HEPES-Na solution pH 7.4 was 
stored at 4-8°C. 
- Hydrogen tetrachloroaurate(III) trihydrate (HAuCl4 -3H2O) (1g, 2.539 mmol) was dissolved in 
water (6.35 mL) to a final concentration of 0.4 M in aurate. This stock solution was stored at 4-
6°C in a brown vial and can be stored for more than 6 months.  
- The 2 M ammonium acetate solution was buffered to pH 4.7 with 2 M acetic acid solution 
using a pH-meter.  
- 5,5’-dithio-bis(2-nitrobenzoic acid) (DTNB) (198.2 mg, 50 µmol) was dissolved in 0.3 M 
aqueous NaOH solution (10 mL) to a final 50 mM DTNB concentration. The orange solution 
was used within 48h and stored at 4-6°C in the dark when not freshly used. 
- Glutathione (GST) solutions were freshly prepared in water and buffered to pH 7.0 using 0.3 M 
NaOH. For the ESI-MS analysis, the glutathione was buffered to pH 7.8 using NH4OH. 
- The 133 mM Sorenson’s buffer, pH 7.4 was prepared by combining 133 mM Na2HPO4 (804 
mL) with 133 mM KH2PO4 (196 mL). After verification of the pH with the pH-meter, the 
solution was filtered for sterilization using a 33 mm syringe-driven filter unit (0.22 µm Millex-
GP, Millipore, Molsheim France). 
- The TEM storage solution was a 0.1 M Sodium cacodylate buffer, pH 7.2 containing 2% (w/v) 
sucrose, 1 mM MgCl2 and 1 mM CaCl2. The solution was filtered for sterilization using a 33 mm 







Estimation of the absorption coefficient of the gold nanocluster. The dried AuZ pellet (4.2 
mg) was dissolved in water (350 µL) and the solution pH was adjusted to 7.0 by addition of 50 
mM aqueous NH4OH to a final concentration of 11.28 g x L-1. Aliquots (1 µL volume) were 
withdrawn and diluted with water (final volume of 700 µL) giving a concentration of 16.114 
mg/L. An optical density (OD) of 0.153 at 520 nm was measured using a 1 cm-path quartz 
cuvette. Using the Beer-Lambert equation (OD = ε l c) and an estimated molecular mass of 
28382 Da (Au102TAB30TNB14), extinction coefficients (ε520) of 9.51 g-1L x cm-1 and 2.7 x 105 
mol-1 x L x cm-1 were determined.  
 
Preparation of gold nanoparticles. The citrate-stabilized gold nanoparticles were prepared 
according to a described procedure.1 After preparation, the particles were purified and 
concentrated using the 0.5 mL Microcon® centrifugal filters (cut-off: 100 kDa). Particle 
concentration was estimated at 116 nM by UV/vis spectrometry using the nanoparticle 
absorption at 509 nm. Next, the gold particles (0.2 nmol) were reacted with the Cap peptide (32 
nmol), HSPEG (32 nmol), Cap/HSNLS (9/1) mixture (32 nmol total) and Cap/HSNLS (9/1) 
mixture (32 nmol total) in 150 mM K2CO3 for 24h at room temperature. The particles were then 
purified and concentrated using the 0.5 mL Microcon® centrifugal filters (cut-off: 100 kDa). 
Concentrations of the peptide-grafteraqueous solutions were spectrophotometrically estimated 
and set at 4 µM. 
 
PolyAcrylamide Gel Electrophoresis. 10% Polyacrylamide Gels (1 mm thick) were casted 
using the BioRad MiniProtean system in 25 mM Tris-186 mM glycine buffer pH 8.3 containing 
0.1 % (w/v) Sodium Dodecyl Sulfate (SDS). For electrophoresis, the running buffer was 25 mM 
Tris-186 mM glycine buffer pH 8.3 containing 0.1 % SDS unless indicated otherwise. The 
polyacrylamide gel was pre-run for 20 min at 90V. For loading in the wells, 50% (v/v) glycerol 
in water was diluted to 10% into samples (5-10 µL volume; 40 nmol in AuNC). The 
electrophoresis was run at room temperature for 45 minutes at 90V. The gold nanoclusters were 
observed as black-brown bands. Peptides were visualized after Coomassie blue staining. 
 
Thermal Gravimetric Analyses. The analysis was performed on a Q 5000IR apparatus (TA 
Instruments) under a flow of nitrogen on vacuum-dried particles (0.2990 mg) and at a heating 
rate of 10°C/min.  
 
Electron Microscopy. Imaging of cells and peptide-modified AuNCs was performed using a 
FEI G2 F20 Transmission Electron Microscope operating at 200 kV. Image acquisition was 
performed on a 2048 x 2048 CCD camera (Ultrascan 1000, Gatan Inc., Pleasanton) by collecting 
25 adjacent images using the SerialEM software (Boulder, Colorado, USA). The final image was 
reconstructed by stitching the adjacent images using the Montage plugin package (Jean Daraspe, 
Université de Lausanne, Switzerland) and the iMod software.2 






applied onto the ultrathin carbon support film of 100 Mesh EM grids (UMC Utrecht, The 
Netherlands). After 1 min. adsorption, the excess liquid was removed with a filter paper.  
For cryo-EM imaging, samples (3 µL) of 10 µM AuNC solution in 10 mM HEPES, pH 7.4 were 
applied to lacey carbon grids, blotted with filter paper from both sides for half a second in the 
temperature- and humidity-controlled Vitrobot Mark IV apparatus (FEI, Eindhoven, Netherlands, 
T = 20°C, humidity 95%, Blot Force 5, Blot time 0.5 sec) and plunge-frozen in liquid ethane pre-
cooled by liquid nitrogen to embed the complex in a thin film of vitrified buffer spanning the 
holes of the carbon film. Images were collected at liquid nitrogen temperature with a FEI Titan 
Krios EM operating at 300 kV with a dose of 20 electrons per Å2 using a FEI Falcon II Camera 
with pixel size of 0.8936 Å, integration time 1s, bining 1 and defocus of -0.5 µm. 
 
MALDI-TOF mass spectrometry. Mass measurements were carried out on an AutoflexTM 
MALDI-TOF mass spectrometer (Bruker Daltonics GmbH, Bremen, Germany). This instrument 
was used at a maximum accelerating potential of 20 kV in positive mode and was operated in 
linear mode at 19 kV. The delay extraction was fixed at 80 ns and the frequency of the laser 
(nitrogen 337 nm) was set at 5 Hz. The acquisition mass range was set to 5000-30000 m/z with a 
matrix suppression deflection (cut-off) set to 500 m/z. The equipment was externally calibrated 
with a standard protein calibration mixture that contained 5 proteins (Bruker Protein Standard II 
#8207234, Bruker Daltonics GmbH, Bremen, Germany) covering the 10,000-70,000 m/z range. 
Each raw spectrum was opened with flexAnalysis 2.4 build 11 (Bruker Daltonics GmbH, 
Bremen, Germany) software. Sample preparation was performed with the dried droplet method 
using a mixture of 0.5 µl of sample with 0.5 µl of matrix solution dried at room temperature. The 
matrix solution was prepared from a saturated solution of α-cyano-4-hydroxycinnamic acid in 
water/acetonitrile 50/50 diluted three fold in water/acetonitrile/trifluoroacetic acid 50/49.9/0.1. 
 
Cell culture. The HeLa (ATCC CCL2) and U2OS (ATCC HTB-96) human cancer cell lines and 
the non-cancer human fibroblast HFF-1 cell line (ATCC SCRC-1041) were maintained in 
Dulbecco’s modified Eagles tissue culture medium (DMEM) supplemented with 10% heat 
inactivated FCS (Life Technologies), 2 mM L-glutamine and antibiotics. Cells were grown in 
humidified atmosphere at 37°C and with 5% CO2. Cells were maintained in culture for less than 










Table S1. Sequence of peptides used for preparing Peptide-grafted AuZ gold clusters  
Abbre 
viation 




GSH Passivation γ−ΕCG (Glutathione) 307.32 3,4 
Cap Protection CALNNG 590.65 5 
NLS Nuclear import CALNNGAGPKKKRKVED 1828.13 6 
dNLS Defective 
nuclear import 
CALNNGAGPKTKRKVED 1801.06 6 











Figure S1. High resolution XPS spectra of AuZ particles a) S 2p and b) C 1s. The S2p3/2 and 
S2p1/2 peaks are consistent with most sulfur atoms being engaged in a coordination bond with 
the gold surface atoms8 The C 1s components at 284.4, 285.6 and 288.6 eV are assigned to 
various carbon species C-C, C-O-C, C-N and C=O, O-C=O respectively,9 in good agreement 









Figure S2. Thermogravimetric curve and derivative weight change curve of the AuZ. 
  





















































Figure S3. Analysis of reaction between AuZ and glutathione (GSH). A. UV/vis spectra of the 
crude reaction (red line), purified GSH-gold nanocluster (AuGS) (blue line) and released low 
molecular weight components (black line). The red dotted arrow pinpoints a novel absorption 
band. B. ElectroSpray Mass Spectrum of the released species after a 20h reaction of AuZ (45.6 
nmol, 200 µL of a 228 µM solution) with Glutathione, pH 7.8 (570 nmol, 5.7 µL of a 0.1 M 
solution). The glutathione solution was freshly prepared and buffered by addition of NH4OH. 
The gold clusters were separated from unreacted glutathione and released species using a 0.5 mL 
microcon-10 kDa centrifugal filter unit. The flow through contained a thionitrobenzoic acid 
(TNB) concentration of 848 µM using the absorption coefficient of 14,150 M-1.cm-1 at 412 nm. 
The mass spectrum was taken 7 days after the reaction.  
 
Comment. The UV/vis spectra of aliquots from the crude reaction, purified AuGS and released 
low molecular mass species were taken into the NMR spectroscopy survey (Figure 3B). The 
crude reaction (red line) exhibited now an UV/vis absorption spectrum corresponding to the sum 
of UV/vis absorption spectra of purified AuGS (blue line) and to released aqueous-soluble 
ligands (black line). The spectrum of the released species was analogous to the spectrum of TNB 
(Figure 1B) with the exception of a light shoulder (red dot arrow), indicating release of another 
ligand from the AuNCs. This absorption band is likely due to TAB. Using an absorption 






TNB at 335 µM. This value corresponds to about 50% of the overall concentration of released 
















Figure S5. MTT Cell viability assay using the HFF-1 normal cell line. Freshly trypsinized HFF-
1 cells (50,000 cells) in presence of the indicated nanoclusters were added in the Neon 
transfection device in conditions that were used for electroporation, with the electric pulses 
(yellow bars) or without electric pulses (blue bars). Cells were then diluted in the cell culture 












Figure S6. Optical microscopy images of U2OS cells incubated for 24h with the indicated 






added to living U2OS cells by dilution in the cell culture medium without an electroporation 
treatment. B, D and F. The U2OS cells were subjected to electroporation in presence of the 
indicated AuNCs. Following the 24h incubation period at 37°C, the living cells were fixed with 
glutaraldehyde (2.5% w/v) and AuNCs were detected by silver staining. Cell viability, estimated 








Figure S7. Optical microscopy images of HFF-1 cells incubated for 24h with the indicated 
peptide-substituted gold nanoclusters (AuNCs). A, C, E and G. The various peptide-AuNCs 
were added to living HFF-1 cells by dilution in the cell culture medium without an 






presence of the indicated AuNCs. Following the 24h incubation period at 37°C, the living cells 
were fixed with glutaraldehyde (2.5% w/v) and AuNCs were detected by silver staining. Cell 










Figure S8. Transmission electron microscopy of untreated HeLa cells. After fixation with 2.5% 
glutaraldehyde, the specimen was treated with the Aurion Silver enhancement solution exactly as 
the AuNCs-containing specimens. After the silver staining, the HeLa cells were processed for 







Figure S9. A. Synthesis of peptide-grafted gold nanoparticle from citrate-gold nanoparticle. B. 
TEM image of the starting gold nanoparticle showing a population of particle with average 
diameter of 4.5 nm. C. SDS-denaturing 15% Polyacrylamide gel electrophoresis of the peptide-








Figure S10. Reactivity and delivery of NLS-grafted gold nanoclusters from AuMBA. A and B. 
Comparative reactivity of the AuZ to the HS-NLS peptide or to an S-alkyl-NLS peptide (R-S-
NLS) and analysis of AuMBA and subsequent reaction with HS-Cap or HS-NLS. Images are 
PAGE images of the same gel before and after Coomassie blue staining. The data indicated that 
our AuMBA batch contains several nanoclusters. We were unable to obtain a batch containing 
only one band. The S-Alkyl-NLS was obtained by reacting the HS-NLS to N-ethylmaleimide 
(1.2 molar equivalent) 30 min before addition to AuZ. Condition 1: 80 µM AuZ, 2 mM HS-NLS 
(or R-SNLS), 0.1 M HEPES, pH 7.4 (10 µL volume). Condition 2. 80 µM AuMBA, 4 mM 
HSCap or 4 mM HSNLS (100 µL volume, 16h reaction). The subsequent particles were purified 
using a 30 kDa UltraConcentrator device. Aliquots were analyzed and the AuMBANLS was 
used for the electroporation treatment (see images D). C. MALDI-TOF Mass spectrum of the 
AuMBA. The results confirmed that our preparation contains several clusters.  D. The HeLa or 
the HFF-1 cells were subjected to electroporation in presence of the AuMBS-NLS. Following the 
24h incubation period at 37°C, the living cells were fixed with glutaraldehyde (2.5% w/v) and 






expected from an NLS-driven nuclear import. The AuMBA-NLS appears to be less effectively 
imported in the HFF-1 nuclei than the AuNLS, suggesting a benefit of the zwitterionic TAB 
shell. Cell viability, estimated by monolayer density was >80%.  
 
Figure S11. Evaluation of the intracellular fate of peptide-subtituted 4.5 nm nanoparticles. A. 
Scheme of the experiment. B. The various gold nanoparticles as indicated were mixed with HeLa 






at 37°C, the living cells were fixed with glutaraldehyde (2.5% w/v) and the gold nanoparticles 
were detected by silver darkening. Results showed heterogeneous distribution. These NLS-
equipped nanoparticles did not accumulate in the cell nuclei even when the nanoparticle’s 
surface was equipped with PEG for minimizing unspecific association to cellular component. We 
did not determine whether the poor cytosolic delivery was due to poor diffusion inside he cytosol 




Figure S12. Fluorescence emission spectra of the AuZ (A) and AuGS (B) nanoclusters at 
various excitation wavelengths as indicated. Results indicated that the AuZ and the AuGS have 
photoluminescent abilities (Ex: 300, Em: 376 nm). The intensity of the photoluminescnet was 
extremely weak and practically useless for in cellulo imaging or nanocluster tracking. Condition: 










Figure S13. HPLC profile and mass spectrometry analysis of the Cap peptide (CALLNG, 
C22H38N809S1 ; MW : 1801.06). Column: 4.6mmx250mm Diamonsil 5 µ C18. Solvent A: 0.1% 










Figure S14. HPLC profile and mass spectrometry analysis of the NLS peptide 






Diamonsil 5 µ C18. Solvent A: 0.1% TFA in 100% Acetonitrile, Solvent B : 0.1% TFA in water. 









Figure S15. HPLC profile and mass spectrometry analysis of the dNLS peptide 
(CALNNGAGPKTKRKVED, C74H129N25O25S1 ; MW : 1801.06). Column 4.6mmx250mm 















Figure S16. HPLC profile and mass spectrometry analysis of the NES peptide 






4.6mmx250mm Inertsil ODS-SP. Solvent A: 0.1% TFA in 100% Acetonitrile, Solvent B: 0.1% 








Figure S17. FT IR spectrum of the AuZ nanocluster. The spectrum was taken using a Nicolet 










Figure S18. FT IR spectrum of the AuGS nanocluster. The spectrum was taken using a Nicolet 










Figure S19. FT IR spectrum of the AuCap nanocluster. The spectrum was taken using a Nicolet 









Figure S20. FT IR spectrum of the AuNLS nanocluster. The spectrum was taken using a Nicolet 








Figure S21. FT IR spectrum of the AudNLS nanocluster. The spectrum was taken using a 












Figure S22. FT IR spectrum of the AuNES nanocluster. The spectrum was taken using a Nicolet 










Figure S23. Synthesis of Alexa488-labeled AuNLS. A. Route for preparing Alexa488-labeled 
AuNLS. AlexaFluo488 NHS ester (ThermoFisher) (16 nmol) was mixed with the HS-NLS (16 
nmol) in 150 mM K2CO3 and incubated for 24h for labeling the peptide on the Lysines. The 
reaction mixture was then treated with TCEP (32 nmol) and then AuZ (8 nmol). After a 24h 
reaction, unlabeled SH-NLSs (240 nmol) and TCEP (240 nmol) were added and the reaction was 
incubated for 24h before purification using an ultracentrifugation device with a 30 kDa cut-off. 
B. UV-vis spectrum of the Alexa488-labeled AuNLS (black line). The green line corresponds to 







Figure S24. Characterization of Alexa488-labeled AuNLS. A. Scheme of experiment done for 
characterizing the AuNLSAlexa488. The nanocluster (0.32 nmol) was treated in water with 
TCEP, pH 7.0 (500 nmol) in a 6 µL volume to perform an oxidative dissolution of the Au(0) and 
to release the ligand from the nanocluster. 10,11 B. PAGE analysis of AuZ, AuNLSAlexa488 and 
the TCEP-treated corresponding nanoclusters as indicated. After analysis, the gel was visualized 
under visible light (left image) or under UV (right image). Data showed AuZ and 
AuNLSAlexa488 to be non-fluorescent (actually they absorb UV light (intense dark band). 
TCEP-treated samples showed release of a fluorescent species (the likely released species are 
indicated in the graph), suggesting that AuNC actually quenches fluorescence. C. Fluorescence 







Comment: data indicated that the TCEP-treated AuNLSAlexa488 released fluorescent species 
whereas AuNLSAlexa488 did not emit the Alexa488 fluorescence. These experiment clearly 
demonstrated that: -1. AuNLSAlexa488 is grafted with the Alexa488, -2. The AuNC quenches 








Figure S25. Analysis of fate of Alexa488-labeled AuNLS after addition to HFF-1 cells. A. 
Images of HFF-1 cells incubated with the AuNLSAlexa488 for 24h. Hoechst 33242-stained cells 
were observed under bright field, blue channel, for detection of Hoechst 33242-stained nuclei, 
and green channel for detection of the Alexa488. B. Images of HFF-1 cells incubated with the 
AuNLSAlexa488 for 24h followed by silver staining. C. Images of electroporated HFF-1 cells 
incubated with the AuNLSAlexa488 for 24h. Hoechst 33242-stained cells were observed using 
phase contrast, under bright field, blue channel (for detection of Hoechst 33242-stained nuclei) 
and green channel for detection of the Alexa488). D. Images of electroporated HFF-1 cells 
incubated with the AuNLSAlexa488 and for 24h followed by silver staining. Following the 24h 
incubation period at 37°C, the living cells were fixed with glutaraldehyde (2.5% w/v). Data 

















Figure S26. Color images of HeLa cells incubated with AuCap, AuNLS and AudNLS. A. 
Untreated cells. B, C and D. The various peptide-AuNCs were added to living HeLa cells by 
dilution in the cell culture medium without an electroporation treatment. E, F and G. The HeLa 
cells were subjected to electroporation in presence of the indicated AuNCs. Following the 24h 
incubation period at 37°C, the living cells were fixed with glutaraldehyde (2.5% w/v) and 









Figure S27. Color images of HeLa cells incubated or 24h with: A. AuNES and leptomycin, or B. 
AuNES alone. The AuNES was added to living HeLa cells by dilution in the cell culture medium 
with an electroporation treatment. Following the 24h incubation period at 37°C, the living cells 
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